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ABSTRACT
To maintain viability, cells must resolve misfolded protein stress; the inability to
do so often triggers cell death, most notably in neurons during neurodegenerative disease.
The NAC is a highly conserved translational chaperone essential for protein folding and
localization to organelles throughout the cell. In C. elegans, depletion of the NAC
initiates misfolded protein stress specifically in the endoplasmic reticulum, inducing a
response that upregulates the HSP-4 chaperone in an attempt to prevent cell death. This
upregulation is robust but not uniform, and deficient in regions containing neurons. We
are characterizing this non-uniform stress response to determine if HSP-4 upregulation is
cell-specific and correlates with survival. Additionally, there is evidence that the NAC
may function in engaging premature and/or atypical differentiation under stress
conditions. We’ve developed a protocol that characterizes the differentiation patterns and
stress responses in NAC-depleted C. elegans. Our results indicate that NAC-depleted C.
elegans have altered gut cell differentiation patterns when compared to control
treatments. Furthermore, control studies were conducted to determine baseline patterns of
HSP-4 expression in relation to the location of gut cells. Future studies will investigate
differentiation patterns of muscle and neuronal cells in NAC-depleted C. elegans as well
as characterizing the upregulation of HSP-4 in gut, muscle, and neuronal cells within
NAC-depleted C. elegans.
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INTRODUCTION
Proteins are versatile macromolecules essential for the function of every cell in
the body. The structure of a protein determines its function and is itself defined by the
content and order of the amino acids that make up the protein. Amino acids form proteins
through dehydration synthesis reactions in which a peptide bond is formed between two
adjacent amino acids. The linking of amino acids forms a chain of peptide bonds that
leads to the formation of the primary structure of a polypeptide. As the chain emerges
from the ribosomal complex during translation, adjacent amino acids interact via
hydrogen bonding to form twists and folds that result in secondary structures, e.g. alpha
helical structures and beta-pleated sheets. Subsequently, secondary structures interact
with each other depending on the nature of their specific amino acid R-groups, which
form ionic bonds, disulfide bridges and hydrophobic interactions and generate the tertiary
structure of the polypeptide. Many amino acid chains become immediately functional
once they have folded into their proper structure, while some interact with other amino
acid chains, forming quaternary structure required for functionality1
Proper protein folding during translation followed by maintenance of that folded
structure are essential for protein function and therefore cell viability. The flow of
information required to generate a functional protein initiates from the nucleus and
terminates in the cytoplasm: a gene is transcribed into a primary mRNA that is processed
to make a mature mRNA. These mRNAs are read by ribosomal complexes, generating a
chain of amino acids that interact to create the initial structure of the polypeptide. The
early stages of protein folding are the foundation for the final protein structure and if not
properly conducted, will result in a misfolded protein that is either nonfunctional or
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differentially functioned. Misfolded proteins often result from exogenous stress on the
cell, and can accumulate in different cellular compartments. Misfolded proteins can cause
damage by forming aggregates that interact with cellular organelles and/or perpetuating
the misfolding of other proteins2. Specifically, the endoplasmic reticulum (ER) is
susceptible to aggregation of misfolded protein during periods of stress generated by
heat, toxins, aging, and nutrient deficiencies; stress events that generate misfolded protein
in the ER can lead to the death of the cell if the stress is chronic or acute3
Under normal conditions, the ER is responsible for the first step in proper protein
folding. The rough ER is responsible for synthesizing nascent polypeptides that will
become functional proteins whereas the smooth ER is responsible for maintaining and
processing these polypeptides4. Under stress conditions, the accumulation of misfolding
peptide chains can overwhelm the folding mechanisms of the ER, resulting in
accumulation and aggregation within the lumen4. To prevent this occurrence, the stressed
cell engages the ER-specific unfolded protein response (UPR), which initiates cell-saving
mechanisms to help alleviate the misfolded protein accumulation and aid the cell in
coping with cell stress5. When the misfolded protein stress is too acute or chronic to
allow for timely resolution, the UPR will initiate mechanisms that kill the cell, primarily
via apoptosis; the UPR-mediated outcome is what putatively links ER misfolded protein
stress to a number of human diseases. By way of an example, most, if not all,
neurodegenerative disease pathologies include the accumulation of misfolded proteins6.
There are multiple hypotheses regarding the origin of the protein accumulation in
neurodegenerative diseases and its contribution to disease progression, including
disrupted function of the ER due to high levels of misfolded proteins not processed
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efficiently before aggregating2,4. Ultimately, the accumulation of misfolded proteins is
thought to trigger cell death as a mechanism to protect the organism; this cell death is
what likely links misfolded protein stress and the subsequent induction of the UPR to the
apoptotic loss of neurons observed during neurodegeneration7.
To establish and maintain properly folded proteins and avoid the damage
associated with misfolded protein stress, the cell expresses chaperones, a family of
proteins dedicated solely to aiding in protein folding. Chaperones are expressed
throughout the cell’s life and constitute the proteostasis network that regulates both
nascent protein folding and the refolding of misfolded proteins8. Chaperones work
individually and in combination to control the folding environment of polypeptides; they
prevent nascent chain misfolding during translation, and refold misfolded proteins to their
native states during stress. When misfolded protein stress becomes acute and/or chronic,
chaperones are also known to shuttle misfolded proteins to degradation pathways9,10.
Individual chaperone functions have been characterized11 as well as the inter-related
interactions that constitute the chaperome, a complex network of cooperative chaperone
relationships that regulate the structures of both nascent proteins and misfolded proteins8.
Within the chaperone family are heat shock proteins (HSPs), a class of
chaperones originally associated with heat stress that bind polypeptides and assist with
folding. Heat shock proteins are ubiquitous and abundant, comprising approximately 1-2
percent of the total proteins within a cell12. Their primary role is to prevent any
misfolding events and aggregation during cell stress13. There are multiple classes of heat
shock proteins, classified by the molecular weight of the founding member, all with
specific functions: small HSPs, HSP40, HSP70, HSP90, and HSP100. Small HSPs
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prevent the initial accumulation of aggregated proteins. If aggregates occur, HSP40
chaperones deliver the aggregated proteins to HSP70 chaperones, which associate with
HSP100 chaperones to dissolve and reactivate misfolded proteins in an ATP-dependent
manner. Once these aggregates have been properly refolded, HSP90 chaperones maintain
this folded state12,14. Of these classes, HSP70 members have been extensively studied and
highly conserved throughout evolution, with a subset, including BiP, specific to the
management of misfolded protein in the ER13.
In addition to the HSPs, there are other classes of chaperones less well
characterized, but still essential for proper protein folding, including those that bind to
nascent polypeptides as they emerge from the ribosome, otherwise known as translational
chaperones. The nascent polypeptide associated complex (NAC) is a translational
chaperone complex that exists as a heterodimer with two subunits, alpha and beta; the
beta subunit is responsible for the NAC’s association with the ribosomal complex15.
Specifically, the NAC is responsible for promoting nascent protein folding as well as
protein localization during translation, and therefore is directly maintains proteostasis and
cell viability16,17. Therefore, the NAC plays an essential role in the control of protein
folding and localization to different organelles and the complete loss of the NAC causes
lethal phenotypes in many organisms, including mice and Drosophila melanogaster.
While the initial characterizations of the NAC were performed primarily in yeast,
recently important insights into the functions of this complex have been gained in
metazoans, including Caenorhabditis elegans (C. elegans). As with mice and Drosophila,
a complete genetic knockout of either subunit of the NAC in C. elegans is embryonically
lethal18. As such, knockdown experimental procedures of the NAC, e.g. through the use
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of RNA interference, is necessary for investigating the roles of this complex in protein
folding. Through depletion of one or the other subunit, it has been determined the
depletion of the NAC in C. elegans results in accumulation of misfolded protein stress in
the ER, presumably due to the mislocalization of poorly folded proteins to the ER in the
absence of NAC’s translational chaperone function16. This accumulation results in the
induction of the UPR, which initiates both cell-saving and cell-killing responses
depending on the severity and duration of the stress19.
The UPR has three key proteins that are variably engaged during a stress
response: IRE-1, ATF6, and PERK/PEK-1. The initial actions of the UPR engage several
cell-saving mechanisms, including an attenuation of translation, increased chaperone
expression, increased protein degradation and turnover, and expansion of the lumenal
area of the ER5. When these cell saving responses are unable to resolve the stress in a
timely fashion, the UPR engages cell killing mechanisms to remove the damaged cell
from the organism. These cell deaths are primarily via apoptosis, although UPR-mediated
autophagy has also been shown to contribute in certain contexts (Figure 1). While the
UPR has been previously characterized in the context of stress response, there is
gathering evidence that the UPR is also engaged to drive the differentiation of certain cell
types5,20.
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Figure 1. The Unfolded Protein Response (UPR) mechanism engaged in the presence of misfolded protein
stress. The three key proteins of the UPR are IRE-1, ATF6, and PERK/PEK-1. The UPR engages several
mechanisms, including translation attenuation, increased chaperone expression, increased protein
degradation and turnover, and ER biogenesis during times of misfolded protein stress. The UPR engages
cell killing mechanisms when the cell-saving mechanisms are unable to resolve the stress. These cell deaths
are via apoptosis and autophagy. Figure adaptation21.

While the NAC is a heterodimer that functions as a translational chaperone, there
is strong evidence that the subunits also function independently of each other. For alpha
NAC, there is compelling evidence for a role as a transcription factor in the regulation of
cell differentiation, consistent with alpha NACs ability to translocate from the cytoplasm
to the nucleus when not bound by beta NAC22. Specifically, alpha NAC helps regulate
osteoblast development in mice22,23. In this role, alpha NAC interacts with histone
deacetylases to both upregulate and downregulate a suite of osteocalcin genes that
promotes osteoblast maturation and bone mineralization during development24,25. In
addition to its role in bone cell differentiation, alpha NAC acts as a positive regulator of
erythroid cell differentiation although there are no specific mechanisms to elucidate this
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pathway currently26. Initially identified and characterized in the context of its role in the
NAC complex, alpha NAC itself appears to have a multitude of functions above and
beyond the protein folding regulation and localization that it performs when bound to
beta NAC.
Alpha NAC has been relatively well characterized in terms of its independent
roles; less is known about the role(s) of beta NAC when not bound by alpha NAC. In the
absence of alpha NAC, beta NAC has the ability to stop ribosome binding to the ER,
likely a reflection of its role to control protein localization during translation. Beyond this
analysis, characterization of beta NAC has been performed in the context of depletion of
the subunit15. Initial studies of beta NAC in C. elegans identified it as a repressor of
apoptosis. Specifically, a decrease in beta NAC levels increases apoptosis early in
embryogenesis, with neurons being particularly susceptible18. Similarly, in human cell
lines, the down-regulation of beta NAC has been correlated with apoptosis27,28. Recent
evidence links beta NAC’s ability to suppress apoptosis and prevention of misfolded
protein stress to the activation of the UPR and subsequent induction of apoptosis16. The
evidence of beta NAC as an inhibitor of apoptosis is based solely on phenotypes
generated in its absence, making it impossible to determine if these results are due to the
loss specifically of beta NAC, the loss of the NAC, or both. In support of beta NAC
having an anti-apoptotic function above and beyond its role in the NAC, overexpression
of beta NAC in the presence of normal expression levels of alpha NAC leads to the
survival of cells that are normally eliminated by apoptosis during embryonic
development29.
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There is ample evidence that the NAC and its individual subunits play important
roles in the management of misfolded protein stress in the ER, as well as potential roles
in the control of certain cell differentiation programs. There is also evidence that stress
induced by the depletion of the NAC is tolerated differentially by different cell types,
with neurons being particularly susceptible to apoptotic cell death. Our research has
focused on the link between the depletion of the NAC and cell-specific responses,
including the putative role(s) of the individual subunit when in excess to its binding
partner. To determine the role of the NAC in cell specific responses to misfolded protein
stress, C. elegans embryos with fluorescently tagged cell lineages, specifically intestinal
cells, were manipulated. In order to characterize both the stress response and the timing
of cell differentiation in these embryos, alpha NAC, beta NAC or both were depleted.
Our hypothesis was that the depletion of either NAC subunit will induce UPR cell-saving
responses in gut cells, while a relative abundance of alpha NAC during the depletion of
beta NAC will drive gut cells to differentiate earlier relative to gut cells in wild-type
organisms.
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METHODS
Care and Maintenance of C. elegans
C. elegans wild-type and mutant worms with GFP and/or RFP reporter constructs were
maintained on Nematode Growth Medium (NGM) (Carolina Biological) plates that
contained the Escherichia coli strain, OP50-1, as a food source. Worms were maintained
at 22 °C. Short term maintenance involved the transfer of adults to freshly seeded OP501/ NGM plates every 3-4 days.

hsp-4::GFP and Cell Lineage Reporter Strains
Heat Shock Protein 4::Green Fluorescent Protein (hsp-4::GFP), the C. elegans homolog
of Heat Shock Protein 70, and Gut::Red Fluorescent Protein (Gut::RFP) strains were
acquired from the Caenorhabditis Genetics Center (CGC) at the University of Minnesota.
The HSP-4 construct consists of the gene expression control region of the specified hsp-4
fused to GFP. The Gut::RFP strain contains a fluorescently tagged Pvha6::mRFPPTS1
attached to the unc119 gene, localizing RFP signal to peroxisomes in intestinal cells.

Bacterial Culture Maintenance
Bacterial cultures of E. coli OP50-1 and strains with RNAi plasmids were prepared
weekly using Luria Broth culture media. Cultures were prepared with 10mL of Luria
Broth and a pure culture inoculate of the respective E. coli strain. Antibiotics were added
to the cultures to prevent unwanted growth of other microorganisms; 50 ug /mL
ampicillin for RNAi plasmid strains and 50 ug /mL streptomycin for OP50-1. Cultures
were incubated with shaking at 37 °C for 12 hours. After 12 hours, cultures were
transferred to sterile 15mL tubes and refrigerated at 3.6 °C.
15	
  

	
  
Mounting C. elegans for microscopy
Slides were prepared by placing a small amount, approximately 100uL, of liquefied
bacteriological agar onto a slide and pressing an additional slide to allow the liquefied
agar to spread. The slides were allowed to sit for approximately two minutes before
removing the top slide to expose the thin layer of agar. Approximately 30uL of M9 salt
solution (22mM KH2PO4, 11mM Na2HPO47H2O, 85mM NaCl, 1mM MgSO4) was
placed onto the center of the thin agar layer to allow for embryo transfer. Approximately
30uL of 3mM levamisole solution, suspended in M9, was placed onto the center of the
thin agar layer to allow for adult transfer. Organisms were transferred from plates, either
NGM agar seeded with E.coli OP50-1 or RNAi plates seeded with E.coli containing
respective plasmids for dsRNA, to slides. The excess bacteria on the slide were removed
from the M9 salt solution using a toothpick with an attached eyelash to move the bacteria
out of the solution. This was done to clear the agar layer of bacteria in order to maintain a
clear visual field for microscopy. Once the bacteria were removed from the solution, a
coverslip was added to the slide. The sides of the coverslip were sealed to prevent the
slide from drying out during observation.

RNA Interference Plates and Cultures
To reduce ICD-1 and ICD-2 protein levels, RNA interference (RNAi) assay was
employed. RNAi assay utilizes double-stranded (ds) RNA specific to the mRNA of a
targeted gene to reduce the levels of the corresponding protein. The gene products of icd1 and icd-2 were targeted by RNAi assays to determine the effects of reductions of ICD-1
and ICD-2 proteins on the expression of gut cells and the HSP-4 protein. Feeder bacteria
expressing the appropriate dsRNA were obtained from Addgene, and grown from single
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colonies in liquid LB by shaking overnight at 37oC.The dsRNA specific to icd-1 and icd2 genes were introduced into larval worms, specifically L4 larvae, using a feeding
method in which NGM plates were seeded with a culture of E. coli OP50-1 constructed
with a plasmid with dsRNA that targeted one or the other subunit. RNAi plates were
made by combining 4.5g NaCl, 25.5g agar, 3.75g peptone, 1.5mL of 2mg/mL uracil,
0.22g CaCl 0.75g of 10mg/ml cholesterol in 1463mL of dH2O. This mixture was
autoclaved, allowed to cool, and 37.5mL of phosphate buffer (pH 6), 1.5mL of 1M
MgSO4, 15uL of 0.1M IPTG (for induction of the dsRNA expression) and 1.5mL of
25mg/mL ampicillin (for selection of the dsRNA-expressing plasmid) were added.

Male Generation
Male C. elegans are typically produced through a chromosomal nondisjunction event
during meiosis to produce an XO organism. To encourage a nondisjunction event, heat
shock was employed. L4 larvae and early adult worms were moved to an NGM plate and
incubated in 30°C for 6 hours. After 6 hours, the plate was removed and returned to 22
°C and organisms were allowed to recover. After organisms recovered, progeny were
observed with a dissection microscope to screen for males. Their characteristic arrow
shaped tail and overall smaller appearance in comparison to hermaphroditic worms
physically identified male C. elegans.

Worm Strain Generation Through Genetic Crosses
Male worms were developed in the gut cell lineage reporter strain through heat shock.
These males were crossed with hermaphrodites from the hsp-4::GFP strain and the F1
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hermaphroditic progeny were and isolated on separate plates. Resulting F2 progeny were
singled onto individual plates and their progeny were characterized for Gut::RFP and
hsp-4::GFP presence. F2 worms producing 100% progeny showing both Gut::RFP and
hsp-4::GFP were considered to be homozygous for the fluorescent alleles of both genes.

RNAi Assay for Embryo Characterization
Twenty to thirty L4 larvae were moved to a seeded RNAi (icd-1(RNAi), icd-2(RNAi), or
icd-1/icd-2(RNAi)) plate, designated plate 1. After 12 hours, the original L4 worms were
moved to plate 2. After worms were moved, the embryos on plate 1 were moved to a
slide and analyzed. After 24 hours, the original L4 worms were moved to plate 3. After
worms were moved, the embryos on plate 2 were moved to a slide and analyzed with
confocal microscopy. After 36 hours, the original L4 worms were moved to plate 4. After
worms were moved, the embryos on plate 3 were moved to a slide and analyzed. After 48
hours, the original L4 worms were taken off plate 4 and sacrificed. After worms were
sacrificed, the embryos on plate 4 were moved to a slide and analyzed. To conduct a
control treatment in which no RNAi was implemented, embryos were moved directly
from an E. coli OP50-1 seeded NGM plate. All observation and analysis was conducted
using confocal microscopy (Figure 2a).
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Figure 2a. RNAi assay protocol diagram for Gut Characterization.

RNAi Assay for Colocalization of Heat Shock Protein 4 and Gut Cell
Twenty to thirty L4 larvae were moved to a seeded RNAi (icd-1(RNAi), icd-2(RNAi), or
icd-1/icd-2(RNAi)) plate, designated plate 1. After 12 hours, the original L4 worms were
moved to plate 2. After worms were moved, the embryos on plate 1 were allowed to
develop for 48 hours. The developed adults were moved to slide and analyzed. After 24
hours, the original L4 worms were moved to plate 3. After worms were moved, the
embryos on plate 2 were allowed to develop for 48 hours. The developed adults were
moved to slide and analyzed. After 36 hours, the original L4 worms were moved to plate
4. After worms were moved, the embryos on plate 3 were allowed to develop for 48
hours. The developed adults were moved to slide and analyzed. After 48 hours, the
original L4 worms were taken off plate 4 and sacrificed. After worms were sacrificed, the
embryos on plate 4 were allowed to develop for 48 hours. The developed adults were
moved to slide and analyzed. To conduct a control treatment in which no RNAi was
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implemented, adult worms were moved directly from an E. coli OP50-1 seeded NGM
plate. All observation and analysis was conducted using confocal microscopy (Figure
2b).

Figure 2b. RNAi assay protocol diagram for Colocalization of Heat Shock Protein 4 and Gut Cell.

Confocal Microscopy for Gut Characterization Embryos
Prepared slides were observed using the Nikon C1 Inverted Laser Scanning Confocal
Microscope. The fluorescent channels used were DsOrange (561nm) to detect Gut::RFP
signal. For DsOrange, the fluorescent channels were set to the following thresholds: the
HV/gain was set to 155, the offset was set to 0, and the laser power was set to 1.44. Each
embryo was observed to determine stage and presence of signal. Stages were determined
according to physical characteristics. The first identifiable stage is 390 to 420 minutes
after first cleavage (comma stage) and is characterized by an invagination from the
embryo shell. The second stage is 460 to 520 minutes after cleavage (two-fold stage) and
is characterized by a larger invagination causing an elongation of the two sides of the
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embryo forming a U-shaped organism. The third stage is 520 minutes to 620 minutes
after cleavage (three-fold stage) and is characterized by an S-shaped organism that has
three distinct folds within the embryo shell. The final stage before hatching is 620
minutes to 800 minutes after cleavage (four-fold stage) and is characterized by an
elongated worm that is shaped like a four-fold. The number of embryos with or without
signal was recorded for each stage. The total number of embryos (separated by stage) that
displayed signal were recorded and divided by the total number of observed embryos.
This value was recorded as a percentage of embryos with signal for each developmental
stage. If there was signal present, a captured Differential Interference Contrast (DIC)
image and fluorescent composite image was saved for further reference and analysis. Z
stack fluorescent images were captured for each respective fluorescent channel for each
embryo.

Confocal Microscopy for Colocalization of Heat Shock Protein 4 and Gut Cell
Prepared slides were observed using the Nikon C1 Inverted Laser Scanning Confocal
Microscope. The fluorescent channels used were DsOrange (561nm) to detect Gut::RFP
signal and GFP (488nm) to detect hsp-4::GFP signal. For DsOrange, the fluorescent
channels were set to the following thresholds: the HV/gain was set to 155, the offset was
set to 0, and the laser power was set to 1.44. For GFP, fluorescent channels were set to
the following thresholds: the HV/gain was set to 133, the offset was set to 0, and the laser
power was set to 1.44. A captured Differential Interference Contrast (DIC) image and
fluorescent composite image was saved for further reference and analysis. Z stack
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fluorescent images were captured for each respective fluorescent channel for each adult
worm.
Digital Analysis with ImageJ for Gut Characterization Embryos
Confocal images were uploaded into ImageJ (National Institute of Health) utilizing the
Bioformats plug-in to interpret the Nikon file format. Images were uploaded as a
hyperstack in grayscale and subsequently analyzed. Utilizing the “Analyze Particle”
function, the bounded region of the embryo, as identified from a captured DIC image,
was analyzed to report the number of particles, the area of the region analyzed, and the
mean intensity per stack in each hyperstack. These data were reported in a Microsoft
Excel file and saved for further analysis.

Digital Analysis with ImageJ for Colocalization of Heat Shock Protein 4 and Gut Cell
Confocal files were uploaded into ImageJ (National Institute of Health) utilizing the
Bioformats plug-in to interpret the Nikon files. Images were uploaded as a hyperstack in
grayscale and subsequently analyzed. The channels of the DsOrange and GFP were split
for colocalization analysis. The “Colocalization” plug-in was set to threshold values of 0.
The composite image was then split into three channels: DsOrange, GFP, and
Colocalized. The Colocalized channel was analyzed with the “Analyze Particle” function
within the bounded region of the adult, as identified from a captured DIC image, to report
the number of particles and the area of the region selected. These data were reported in a
Microsoft Excel file and saved for further analysis.

Statistical Analysis for Gut Characterization Embryos
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The excel files containing data from the ImageJ (National Institute of Health) analysis
were compiled into a single Microsoft Excel file and analyzed. The average pixels per
area unit were determined by dividing the sum of pixel counts by the sum of total area
analyzed for each individual stack within the embryo to determine the overall average
pixels per area unit for the entire hyperstack. Additionally, the mean pixel intensity per
stack was averaged to determine the overall mean pixel intensity for the entire
hyperstack. Data from comma and two-fold embryos was not analyzed due to lack signal
in all observed embryos. Each data set from the three-fold and four-fold stages were
separated based on time point (12 hour, 24 hour, 36 hour or 48 hour). Once data was
compiled, the 48 hour time point was disregarded due to lack of discernable embryos and
lack of data points for analysis. After data was compiled by time point and by stage, the
data were averaged and standard deviation was determined for each time point and stage
for each RNAi treatment. A two-way ANOVA was conducted to compare different time
points of each RNAi treatment separated by stage for mean pixels per area unit and mean
pixel intensity. Additionally, a Tukey post-hoc test was conducted to determine any
statistically significant difference between the time points for each treatment and stage.
Another two-way ANOVA was conducted to compare different RNAi treatments at each
time point separated by stage for mean pixels per area unit and mean pixel intensity.
Additionally another Tukey post-hoc test was conducted to determine any statistically
significant difference between the RNAi treatments for each time point and stage.
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RESULTS
Depletion of the ICD-1 and/or ICD-2 subunit significantly affects percentage of embryos
expressing RFP signal
To characterize the effect of NAC individual subunit depletion on the presence of
gut cells, ICD-1, ICD-2, and ICD-1/ICD-2 depleted embryos were examined for reporter
signal. Signal from the Gut::Red Fluorescent Protein (RFP) strain worm, containing a
fusion gene, localizes an RFP signal to peroxisomes in intestinal cells. Therefore the
presence of RFP is indicative of gut cell differentiation. During observation, the presence
of RFP was only seen beginning in the third stage (520 minutes to 620 minutes after
cleavage, three-fold stage) and continuing into the fourth stage (620 minutes to 800
minutes after cleavage, four-fold stage). The number of embryos with or without signal
was recorded for each stage. The total number of embryos (separated by stage) that
displayed RFP was recorded and divided by the total number of observed embryos. The
number of embryos produced at the 48 hour time point was dramatically diminished, and
those that were present were extremely disrupted morphologically as to be indiscernible
due to the prolonged RNAi exposure. Therefore, the 48 hour time point was excluded
from further data analysis.
The percentages of three-fold embryos with RFP signal during icd-1(RNAi)
treatment by time points (12 hours, 24 hours, and 36 hours) were: 47.83%, 54.69%, and
38.00%, respectively, while during icd-2(RNAi) treatment, they were: 32.61%, 25.97%,
and 16.16%, respectively. The percentages of three-fold embryos with RFP signal during
icd-1/icd-2(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were:
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55.56%, 20.51%, and 29.73%, respectively. The percentage of untreated three-fold
embryos with RFP signal was 90.91% (Table 1).

Table 1. Percentage of three-fold stage embryos with RFP signal in comparison to total
number of embryos viewed during indicated RNAi treatment .
Percentage of three-fold embryos with RFP signal
icd-1(RNAi)
icd-2(RNAi)
icd-1/icd-2(RNAi)
Control
12 hours
47.83
32.61
55.56
90.91
24 hours
54.69
25.97
20.51
36 hours
38.00
16.16
29.73
The percentages of four-fold embryos with RFP signal during icd-1(RNAi)
treatment by time points (12 hours, 24 hours, and 36 hours) were: 60.00%, 38.89%, and
52.94%, respectively while during icd-2(RNAi) treatment, they were: 44.44%, 66.67%,
and 23.68%, respectively. The percentages of four-fold embryos with RFP signal during
icd-1/icd-2(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were:
66.67%, 53.33%, and 31.82%, respectively. The percentage of untreated four-fold
embryos with RFP signal was 80.00% (Table 2).
Table 2. Percentage of four-fold stage embryos with RFP signal in comparison to total
number of embryos viewed during indicated RNAi treatment.
Percentage of four-fold embryos with RFP signal
icd-1(RNAi)
icd-2(RNAi)
icd-1/icd-2(RNAi)
Control
12 hours
60.00
44.44
66.67
80.00
24 hours
38.89
66.67
53.33
36 hours
52.94
23.68
31.82
In general, as time of exposure to RNAi treatment increased, the percent of
embryos with signal decreased. When three-fold embryos expressing RFP were
compared, different localization patterns were present. Most strikingly, icd-1(RNAi)
three-fold embryos displayed larger, punctate Gut::RFP aggregations relative to the other
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treatment groups and the control treatment (Figure 3). Four-fold stage embryos
expressing RFP during all RNAi treatments displayed large, punctate signals similar to
icd-1(RNAi) three-fold embryos, but in all cases, this pattern was more widespread
throughout the gut (Figure 4). To characterize and quantify the similarities and
differences of Gut::RFP signal among the different treatment groups, all further data
analyses were done on three-fold and four-fold embryos displaying fluorescent signal.
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Figure 3. RFP signal in three-fold stage embryos after 24 hours of exposure to
specific RNAi treatments. C. elegans with a Gut::RFP expression vector were fed (A)
icd-1(RNAi)-specific bacteria, (B) icd-2(RNAi)-specific bacteria, (C) icd-1(RNAi)specific bacteria and icd-2(RNAi)-specific bacteria, or (D) OP50-1 (E. coli) bacteria
expressing no double stranded RNA for 24 hours, and their progeny embryos were
randomly assessed for expression of RFP using confocal microscopy. DIC and
fluorescent images were overlaid with ImageJ software. Arrow indicates large, punctate
Gut::RFP signal.
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Figure 4. RFP signal in four-fold stage embryos after 24 hours of exposure to
specific RNAi treatments. C. elegans with a Gut::RFP expression vector were fed (A)
icd-1(RNAi)-specific bacteria, (B) icd-2(RNAi)-specific bacteria, (C) icd-1(RNAi)specific bacteria and icd-2(RNAi)-specific bacteria, or (D) OP50-1 (E. coli) bacteria
expressing no double stranded RNA for 24 hours, and their progeny embryos were
randomly assessed for expression of RFP using confocal microscopy. DIC and
fluorescent images were overlaid with ImageJ software. Arrow indicates large, punctate
Gut::RFP signal.
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Depletion of the ICD-1 and/or ICD-2 subunit significantly affects levels of RFP
expression in embryos
The qualitative differences in RFP expression patterns observed between RNAi
treatment groups led us to ask if depletion of different NAC subunits resulted in
significant quantitative differences in RFP expression. One measure of these putative
differences in expression is to quantify the amount of RFP fluorescence expressed in
individual embryos, otherwise known as mean pixels (RFP signal) per area unit (the
embryo).
To determine the effect of NAC individual subunit depletion on the amount of
RFP expressed per embryo, ICD-1, ICD-2, and ICD-1/ICD-2 depleted embryos were
examined and the mean pixels per area unit (arbitrary units) of each embryo was
calculated from the image analysis data output. The mean pixels per area unit values for
individual icd-1(RNAi) treated three-fold embryos by time points (12 hours, 24 hours,
and 36 hours) were: 78.26 ± 22.55, 58.11 ± 23.17, and 58.10 ± 21.04, respectively, while
for icd-2(RNAi) treated embryos, mean pixels per area unit for the same time points
were: 61.45 ± 19.57, 44.41 ± 34.15, and 51.38 ± 42.73, respectively. The mean pixels per
area unit for individual icd-1/icd-2(RNAi) treated three-fold embryos by time points (12
hours, 24 hours, and 36 hours) were: 36.41 ± 22.04, 46.29 ± 14.41, and 49.89 ± 14.55,
respectively. Untreated embryos displayed a mean pixels per area unit value of 13.18 ±
7.91 (Table 3).

29	
  

	
  
Table 3. Average level of RFP expression in three-fold embryos after exposure to
specific RNAi treatments over time. Mean pixels per area unit (arbitrary units) for
individual three-fold stage embryos exposed to icd-1(RNAi), icd-2(RNAi), or icd-1/icd2(RNAi) were determined every 12 hours for 36 hours as a measure of RFP expression,
and expressed as an average.
Average level of RFP expression in individual embryos
icd-1 RNAi
icd-2 RNAi
icd-1/icd-2 RNAi Control
12 hours
78.26 ± 22.55
61.45 ± 19.57
36.41 ± 22.04
13.18 ± 7.91
24 hours
58.11 ± 23.17
44.41 ± 34.15
46.29 ± 14.41
36 hours
58.10 ± 21.04
51.38 ± 42.73
49.89 ± 14.55
The results of these experiments were analyzed with a two-way ANOVA to
determine the statistical significance between the treatments for each time point (Figure
5A-C). When the 12 hour time point of the three-fold stage embryos was compared, icd1(RNAi), icd-2(RNAi), icd-1/icd-2(RNAi) and control treatments had statistically
significant differences relative to each other with a p-value of <0.0001. A Tukey post-hoc
test is conducted if there is a statistically significant difference present from the ANOVA.
An ANOVA test examines if there are any differences present between the treatments
where as a Tukey post-hoc test examines the differences between each treatment in
comparison to the other individual treatments. A Tukey post-hoc test indicated that the
differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and
control treatments with an alpha value of 0.05. Additionally, the post-hoc test indicated
statistically significant differences between all RNAi (icd-1 to icd-2, icd-1 to icd-1/icd-2,
and icd-2 to icd-1/icd-2) treatments with an alpha value of 0.05. When the 24 hour time
point of the three-fold stage embryos was compared, RNAi (icd-1(RNAi), icd-2(RNAi),
icd-1/icd-2(RNAi)) and control treatments had statistically significant differences with a
p-value of <0.0001. A Tukey post-hoc test indicated that the differences lie between the
RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments with an

30	
  

	
  
alpha value of 0.05. When the 36 hour time point of the three-fold stage embryos was
compared, RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control
treatments had statistically significant differences with a p-value of <0.0001. A Tukey
post-hoc test indicated that the differences lie between the RNAi (icd-1(RNAi), icd2(RNAi), icd-1/icd-2(RNAi)) and control treatments with an alpha value of 0.05.
The mean pixels per area unit data were also analyzed with a two-way ANOVA to
determine the statistical significance between the time points within each treatment
(Figure 5D-F). When the three-fold stage embryos exposed to icd-1(RNAi) treatment
were compared, the 12 hour, 24 hour, and 36 hour had statistically significant differences
with a p-value of 0.0030. A Tukey post-hoc test indicated that the differences lie between
the 12 hour to the 24 hour and the 12 hour to the 36 hour with an alpha value of 0.05.
When the three-fold stage embryos exposed to icd-2(RNAi) treatment were compared,
the 12 hour, 24 hour, and 36 hour did not have a statistically significant difference with a
p-value of 0.3452. When the three-fold stage embryos exposed to icd-1/icd-2(RNAi)
treatment were compared, the 12 hour, 24 hour, and 36 hour did not have a statistically
significant difference with a p-value of 0.2151.
At all time points (12, 24, and 36 hours) of exposure to RNAi treatments, the
three-fold stage embryos exposed to the icd-1(RNAi) treatment had the largest value of
mean pixels per area unit while the control treatment had the smallest value (Figure 5AC). Under icd-1(RNAi) and icd-2(RNAi) treatments, the three-fold stage embryos within
the 12 hour time point had the largest value of mean pixels per area unit whereas the 24
hour time point had the smallest value (Figure 5D-E). Alternatively, under icd-1/icd2(RNAi) treatment, three-fold stage embryos within the 36 hour time point had the
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largest value of mean pixels per area unit and the 12 hour time point had the smallest
value (Figure 5F).

Figure 5. Average RFP expression levels for three-fold stage embryos exposed to
specific RNAi treatments for increasing amounts of time. C. elegans with a Gut::RFP
expression vector were exposed to the indicated RNAi treatment or OP50-1 (E. coli)
bacteria expressing no double stranded RNA and their progeny embryos were randomly
assessed for expression of RFP using confocal microscopy. Images were processed to
determine the mean pixels per area unit with ImageJ software. (A) 12 hour time point of
RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments. (B) 24
hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control
treatments. (C) 36 hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd2(RNAi)) and control treatments. (D) 12, 24, and 36 hour time points for icd-1(RNAi)
treatment. (E) 12, 24, and 36 hour time points for icd-2(RNAi) treatment. (F) 12, 24, and
36 hour time points for icd-1/icd-2(RNAi) treatment. Black asterisks indicate statistically
significant difference between RNAi treatment and control treatment. Red asterisks
indicate statistically significant difference between RNAi treatments. Blue asterisks
indicate statistically significant difference between time points.
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The mean pixels per area unit values for individual four-fold embryos exposed to
icd-1(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) four-fold were:
76.51 ± 46.48, 43.84 ± 18.01, and 71.07 ± 42.08, respectively, while for those exposed to
icd-2(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) four-fold were:
63.92 ± 22.50, 37.31 ± 22.41, and 71.88 ± 48.77, respectively. The mean pixels per area
unit values for individual four-fold embryos exposed to icd-1/icd-2(RNAi) treatment by
time points (12 hours, 24 hours, and 36 hours) four-fold were: 39.25 ± 31.10, 42.62 ±
14.78, and 45.23 ± 20.38, respectively. Untreated embryos displayed a mean pixels per
area unit value of four-fold 15.58 ± 6.07 (Table 4).

Table 4. Average level of RFP expression in four-fold embryos after exposure to specific
RNAi treatments over time. Mean pixels per area unit (arbitrary units) for individual
four-fold stage embryos exposed to icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)
were determined every 12 hours for 36 hours as a measure of RFP expression, and
expressed as an average.
Average level of RFP expression in individual embryos Four-fold
icd-1(RNAi)
icd-2(RNAi)
icd-1/icd-2(RNAi)
Control
12 hours 76.51 ± 46.48
63.92 ± 22.50
39.25 ± 31.10
15.58 ± 6.07
24 hours 43.84 ± 18.01
37.31 ± 22.41
42.62 ± 14.78
36 hours 71.07 ± 42.08
71.88 ± 48.77
45.23 ± 20.38
The mean pixels per area unit data were analyzed with a two-way ANOVA to
determine the statistical significance between the treatments for each time point (Figure
6A-C). When the 12 hour time point of the four-fold stage embryos was compared, RNAi
(icd-1(RNAi), icd-2(RNAi), icd-1/icd-2(RNAi)) and control treatments had statistically
significant differences with a p-value of <0.0001. A Tukey post-hoc test indicated that
the differences lie between the icd-1(RNAi) and icd-2(RNAi) treatments and the control
with an alpha value of 0.05. Additionally, the post-hoc test indicated statistically
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significant differences between icd-1 RNAi and icd-1/icd-2(RNAi) treatments with an
alpha value of 0.05. When the 24 hour time point of the four-fold stage embryos was
compared, RNAi (icd-1(RNAi), icd-2(RNAi), icd-1/icd-2(RNAi)) and control treatments
had statistically significant differences with a p-value of <0.0001. A Tukey post-hoc test
indicated that the differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd1/icd-2(RNAi)) and the control treatment with an alpha value of 0.05. When the 36 hour
time point of the four-fold stage embryos was compared, RNAi (icd-1(RNAi), icd2(RNAi), or icd-1/icd-2(RNAi)) and control treatments had statistically significant
differences with a p-value of <0.0001. A Tukey post-hoc test indicated that the
differences lie between the icd-1(RNAi) and icd-2(RNAi) treatments and the control with
an alpha value of 0.05.
The mean pixels per area unit data were also analyzed with a two-way ANOVA to
determine the statistical significance between the time points within each treatment
(Figure 6D-F). When the four-fold stage embryos exposed to icd-1(RNAi) treatment were
compared, the 12 hour, 24 hour, and 36 hour did not have a statistically significant
difference with a p-value of 0.0696. When the four-fold stage embryos exposed to icd2(RNAi) treatment were compared, the 12 hour, 24 hour, and 36 hour had statistically
significant differences with a p-value of 0.0205. A Tukey post-hoc test indicated that the
differences lie between the 24 hour and 36 hour time points with an alpha value of 0.05.
When the four-fold stage embryos exposed to icd-1/icd-2(RNAi) treatment were
compared, the 12 hour, 24 hour, and 36 hour did not have a statistically significant
difference with a p-value of 0.8831.
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At the 12 and 24 hour time points of exposure to RNAi treatments, the four-fold
stage embryos exposed to icd-1(RNAi) treatment had the largest value of mean pixels per
area unit while the control treatment had the smallest value (Figure 6A-B). At the 36 hour
time point of exposure to RNAi treatments, four-fold stage embryos exposed to the icd2(RNAi) treatment had the largest value of mean pixels per area unit and the control
treatment had the smallest value (Figure 6C). Under icd-1(RNAi) treatment, the four-fold
stage embryos within the 24 hour time point had the largest value (Figure 6D).
Additionally, under the icd-2(RNAi) treatment, four-fold stage embryos within the 12
hour time point had the largest value (Figure 6E). Finally, under icd-1/icd-2(RNAi)
treatment, four-fold stage embryos within the 36 hour time point had the largest value of
mean pixels per area unit and the 12 hour time point had the smallest (Figure 6F).
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Figure 6. Average RFP expression levels for four-fold stage embryos exposed to
specific RNAi treatments for increasing amounts of time. C. elegans with a Gut::RFP
expression vector were exposed to the indicated RNAi treatment or OP50-1 (E. coli)
bacteria expressing no double stranded RNA and their progeny embryos were randomly
assessed for expression of RFP using confocal microscopy. Images were processed to
determine the mean pixels per area unit with ImageJ software. (A) 12 hour time point of
RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments. (B) 24
hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control
treatments. (C) 36 hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd2(RNAi)) and control treatments. (D) 12, 24, and 36 hour time points for icd-1(RNAi)
treatment. (E) 12, 24, and 36 hour time points for icd-2(RNAi) treatment. (F) 12, 24, and
36 hour time points for icd-1/icd-2(RNAi) treatment. Black asterisks indicate statistically
significant difference between RNAi treatment and control treatment. Red asterisks
indicate statistically significant difference between RNAi treatments. Blue asterisks
indicate statistically significant difference between time points.
The mean pixels per area unit data were also analyzed with a Student’s T-test to
determine the statistical significance between the stages for each time point within each
treatment (Table 5). The comparison of the 24 hour time point within the icd-1(RNAi)
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treatment between the three-fold and the four-fold stage embryos had a statistically
significant difference with a p-value of 0.0446. The remainder of the comparisons of each
individual time point for each specific RNAi treatment between the two stages of
embryos did not show any statistically significant differences as indicated by p-values
greater than 0.05 (Table 5).

Table 5. Calculated p-values from Student’s T-tests for the comparison of the mean
pixels per unit area of three-fold and four-fold stage embryos relative to each other.
icd-1(RNAi)
icd-2(RNAi)
icd-1/icd-2(RNAi)
12
24
36
12
24
36
12
24
36
hours hours hours hours hours hours hours hours hours
p-value
0.887 0.044 0.282 0.581 0.458 0.284 0.823 0.623 0.577
Overall from the Student’s T test, the three-fold and four-fold stages were not
significantly different for expression of RFP at any time point for any of the RNAi
treatments. However, the icd-1(RNAi) at the 24 hour time point was statistically
significant between three-fold and four-fold stage embryos. Conversely, both three-fold
and four-fold stage embryos showed significant differences in RFP expression at all time
points for all RNAi treatments (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) when
compared to controls.

Depletion of the ICD-1 and/or ICD-2 subunit significantly affects intensity of RFP signal
in embryos
The qualitative differences in the intensity of RFP signal, particularly in the large
punctate structures observed between RNAi treatment groups (Figures 3 and 4) led us to
ask if depletion of different NAC subunits resulted in significant quantitative differences
in intensity of RFP signal. Such differences may correlate strength of stress response
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and/or rate of progression through differentiation with specific RNAi treatments. One
measure of these putative differences in signal intensity is to quantify the strength of RFP
fluorescence expressed in each individual embryo in a given treatment group, otherwise
known as mean pixel intensity.
To determine the effect of NAC individual subunit depletion on the intensity of
RFP signal in individual embryos, ICD-1, ICD-2, and ICD-1/ICD- 2 depleted embryos
were examined and the mean pixel intensity (arbitrary units) was calculated from the
image analysis output. The mean intensity values for three-fold embryos exposed to icd1(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were: 627.97 ±
224.31, 588.91 ± 119.09, and 554.69 ± 65.96, respectively, while those exposed to icd2(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were: 443.73 ±
44.17, 418.70 ± 42.69, and 425.31 ± 23.63, respectively. The mean intensity values for
three-fold embryos exposed to icd-1/icd-2(RNAi) treatment by time points (12 hours, 24
hours, and 36 hours) were: 631.92 ± 48.09, 582.04 ± 27.63, and 583.62 ± 64.27,
respectively. The mean intensity value for the control treatment was 1511.71 ± 330.52
(Table 6).

Table 6. Average intensity of RFP signal in three-fold embryos after exposure to specific
RNAi treatments over time. Mean pixel intensity (arbitrary units) for three-fold stage
embryos exposed to icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi) were determined
every 12 hours for 36 hours as a measure of RFP signal intensity and expressed as an
average.
Three Fold Mean Intensity
icd-1(RNAi)
icd-2(RNAi)
icd-1/icd-2(RNAi)
Control
12 hours 627.97 ± 224.31 443.73 ± 44.17 631.92 ± 48.09
1511.71 ± 330
24 hours 588.91 ± 119.09 418.70 ± 42.69 582.04 ± 27.63
36 hours 554.69 ± 65.96
425.31 ± 23.63 583.62 ± 64.27
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The mean pixel intensity data were analyzed with a two-way ANOVA to
determine the statistical significance between the treatments for each time point (Figure
7A-C). When the 12 hour time point of the three-fold stage embryos was compared,
RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments had
statistically significant differences with a p-value of <0.0001. A Tukey post-hoc test
indicated that the differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd1/icd-2(RNAi)) treatments and the control treatment with an alpha value of 0.05. When
the 24 hour time point of the three-fold stage embryos was compared, RNAi (icd1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments had statistically
significant differences with a p-value of <0.0001. A Tukey post-hoc test indicated that
the differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi))
treatments and the control treatment with an alpha value of 0.05. When the 36 hour time
point of the three-fold stage embryos was compared RNAi (icd-1(RNAi), icd-2(RNAi),
or icd-1/icd-2(RNAi)) and control treatments had statistically significant differences with
a p-value of <0.0001. A Tukey post-hoc test indicated that the differences lie between the
RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) treatments and the control
treatment with an alpha value of 0.05.
The mean pixel intensity data were also analyzed with a two-way ANOVA to
determine the statistical significance between the time points within each treatment.
When the three-fold embryos exposed to icd-1(RNAi) treatment were compared, the 12
hour, 24 hour, and 36 hour did not have a statistically significant difference with a pvalue of 0.2935. When the three-fold stage embryos exposed to icd-2(RNAi) treatment
were compared, the 12 hour, 24 hour, and 36 hour did not have a statistically significant
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difference with a p-value of 0.1613. When the three-fold stage embryos exposed to icd1/icd-2(RNAi) treatment were compared, the 12 hour, 24 hour, and 36 hour did not have
a statistically significant difference with a p-value of 0.0657.
At the 12 hour, 24 hour, and 36 hour time point of exposure to RNAi treatments,
the three-fold stage embryos exposed to icd-2(RNAi) treatment had the smallest value of
mean pixel intensity while the control treatment had the largest value (Figure 7A-C).
Under RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) treatment, the three-fold
stage embryos within the 12 hour time point had the largest value (Figure 7D-F).
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Figure 7. Average RFP intensity levels for three-fold stage embryos exposed to
specific RNAi treatments for increasing amounts of time C. elegans with a Gut::RFP
expression vector were exposed to the indicated RNAi treatment or OP50-1 (E. coli)
bacteria expressing no double stranded RNA and their progeny embryos were randomly
assessed for level of RFP intensity using confocal microscopy. Images were processed to
determine the mean pixel intensity with ImageJ software. (A) 12 hour time point of RNAi
(icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments. (B) 24 hour
time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control
treatments. (C) 36 hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd2(RNAi)) and control treatments. (D) 12, 24, and 36 hour time points for icd-1(RNAi)
treatment. (E) 12, 24, and 36 hour time points for icd-2(RNAi) treatment. (F) 12, 24, and
36 hour time points for icd-1/icd-2(RNAi) treatment. Black asterisks indicate statistically
significant difference between RNAi treatment and control treatment. Red asterisks
indicate statistically significant difference between RNAi treatments. Blue asterisks
indicate statistically significant difference between time points.
The mean intensity values (arbitrary units) for four-fold stage embryos exposed to
icd-1(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were: 589.44 ±
244.27, 606.03 ± 76.55, and 510.19 ± 75.58, respectively while those exposed to icd-
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2(RNAi) treatment by time points (12 hours, 24 hours, and 36 hours) were: 436.63 ±
53.70, 409.83 ± 45.58, and 420.30 ± 27.45, respectively. The mean intensity values for
four-fold embryos exposed to icd-1/icd-2(RNAi) treatment by time points (12 hours, 24
hours, and 36 hours) were: 594.01 ± 54.52, 603.34 ± 53.50, and 619.86 ± 66.25,
respectively. The mean intensity value for the control treatment was 1481.96 ± 295.83
(Table 7).

Table 7. Average intensity of RFP signal in four-fold embryos after exposure to specific
RNAi treatments over time. Mean pixel intensity (arbitrary units) for four-fold stage
embryos exposed to icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi) were determined
every 12 hours for 36 hours as a measure of RFP signal intensity and expressed as an
average.

12 hours
24 hours
36 hours

icd-1(RNAi)
589.44 ± 244.27
606.03 ± 76.55
510.19 ± 75.58

Four-fold Mean Intensity
icd-2(RNAi)
icd-1/icd-2(RNAi)
436.63 ± 53.70
594.01 ± 54.52
409.83 ± 45.58
603.34 ± 53.50
420.30 ± 27.45
619.86 ± 66.25

Control
1481.96 ± 295.83

The mean pixel intensity data were analyzed with a two-way ANOVA to
determine the statistical significance between the treatments for each time point (Figure
8A-C). When the 12 hour time point of the four-fold stage embryos was compared, RNAi
(icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments had
statistically significant differences with a p-value of <0.0001. A Tukey post-hoc test
indicated that the differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd1/icd-2(RNAi)) treatments and the control treatment with an alpha value of 0.05. When
the 24 hour time point of the four-fold stage embryos was compared, RNAi (icd1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments had statistically
significant differences with a p-value of <0.0001. A Tukey post-hoc test indicated that
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the differences lie between the RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi))
treatments and the control treatment with an alpha value of 0.05. Additionally, the posthoc test indicated statistically significant differences between icd-1(RNAi) and icd2(RNAi) treatments with an alpha value of 0.05. When the 36 hour time point of the fourfold stage embryos was compared, RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd2(RNAi)) and control treatments had statistically significant differences with a p-value of
<0.0001. A Tukey post-hoc test indicated that the differences lie between the RNAi (icd1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) treatments and the control treatment with
an alpha value of 0.05.
The mean pixel intensity unit data were also analyzed with a two-way ANOVA to
determine the statistical significance between the time points within each treatment
(Figure 8D-F). When the four-fold stage embryos exposed to icd-1(RNAi) treatment were
compared, the 12 hour, 24 hour, and 36 hour did not have a statistically significant
difference with a p-value of 0.2916. When the four-fold stage embryos exposed to icd2(RNAi) treatment were compared, 12 hour, 24 hour, and 36 hour did not have a
statistically significant difference with a p-value of 0.3640. When the four-fold stage
embryos exposed to icd-1/icd-2(RNAi) treatment were compared, 12 hour, 24 hour, and
36 hour did not have a statistically significant difference with a p-value of 0.6906.
At the 12 hour, 24 hour, and 36 hour time point of exposure to RNAi treatments,
the four-fold stage embryos exposed to icd-2(RNAi) treatment had the smallest value of
mean pixel intensity while the control treatment had the largest value (Figure 8A-C).
Under icd-1(RNAi) treatment, the four-fold embryos within the 24 hour time point had
the largest value (Figure 8D). Under the icd-2(RNAi) treatment, the four-fold embryos
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within the 12 hour time point had the largest value (Figure 8E). Under the icd-1/icd2(RNAi) treatment, the four-fold embryos within the 36 hour time point had the largest
value (Figure 8F).
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Figure 8. Average RFP intensity levels for four-fold stage embryos exposed to
specific RNAi treatments for increasing amounts of time. C. elegans with a Gut::RFP
expression vector were exposed to the indicated RNAi treatment or OP50-1 (E. coli)
bacteria expressing no double stranded RNA and their progeny embryos were randomly
assessed for level of RFP intensity using confocal microscopy. Images were processed to
determine the mean pixel intensity with ImageJ software. (A) 12 hour time point of RNAi
(icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control treatments. (B) 24 hour
time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd-2(RNAi)) and control
treatments. (C) 36 hour time point of RNAi (icd-1(RNAi), icd-2(RNAi), or icd-1/icd2(RNAi)) and control treatments. (D) 12, 24, and 36 hour time points for icd-1(RNAi)
treatment. (E) 12, 24, and 36 hour time points for icd-2(RNAi) treatment. (F) 12, 24, and
36 hour time points for icd-1/icd-2(RNAi) treatment. Black asterisks indicate statistically
significant difference between RNAi treatment and control treatment. Red asterisks
indicate statistically significant difference between RNAi treatments. Blue asterisks
indicate statistically significant difference between time points.
The mean pixel intensity data were also analyzed with a Student’s T-test to
determine the statistical significance between the stages for each time point within each
treatment (Table 8). The comparisons of each individual time point for each specific
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RNAi treatment between the two stages of embryos did not show any statistically
significant differences as indicated by p-values greater than 0.05 (Table 8).	
  

Table 8. Calculated p-values from Student’s T-tests for the comparison of the mean pixel
intensity of three-fold and four-fold stage embryos relative to each other.
icd-1 RNAi
icd-2 RNAi
icd-1/icd-2 RNAi
12
24
36
12
24
36
12
24
36
hours hours hours hours hours hours hours hours hours
0.6752
0.6217 0.1234 0.7344 0.5393 0.6353 0.1367 0.3342 0.2660
p-value
Colocalization of HSP-4::GFP/Gut::RFP under control treatment
Previous studies on the management of misfolded protein stress in C. elegans identified
cell-types specific differences in stress response outcomes induced by depletion of the
NAC. Neurons appeared more sensitive to apoptosis in response to misfolded protein
stress relative to other cell types, e.g. gut cells, due possibly to the sub-optimal expression
of the UPR-specific chaperone HSP-4 16,18. These studies speculate as to, but do not
confirm, the nature of the cell types expressing and not expressing detectible levels of
HSP-4 in response to misfolded protein stress. To determine if gut cells are resistant to
NAC-depletion induced apoptosis due to the upregulation of HSP-4, we planned to
determine the putative co-localization of the HSP-4::green fluorescent protein (GFP)
reporter protein with Gut::RFP. Before these experiments can be performed though, we
established the localization patterns of both fluorescent proteins in untreated animals.
To establish a baseline expression pattern that will allow us to characterize the
effect of NAC individual subunit depletion on the colocalization of gut cells and heat
shock protein 4 (HSP-4), untreated embryos expressing both reporter constructs were
allowed to develop into adults (48 hours post first cleavage) and subsequently examined
for Gut::RFP and HSP-4::GFP. Adult worms were observed with confocal microscopy to
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determine a baseline expression of signal for HSP-4::GFP and Gut::RFP signals. Once
images were captured, fluorescent signal was quantified by calculating mean colocalized
pixels per area unit (arbitrary units), which was 0.6337± 0.0734. The adults were
analyzed with a Colocalization program within ImageJ (National Institute of Health) to
give an output image with only the colocalized areas to determine the amount of
overlapping signal from the HSP-4::GFP signal and the Gut::RFP signal. Additionally, all
fluorescent channels and DIC images were overlaid to show colocalization patterns.
Colocalization, as indicated by the yellow color, was primarily localized to the anterior
and posterior regions of the gut (Figure 9).
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Figure 9. Adult HSP-4::GFP/Gut::RFP worm under control treatment. C. elegans
with the hsp-4::GFP and Gut::RFP expression vectors were fed OP50-1 (E. coli) bacteria
expressing no double stranded RNA and their progeny embryos were allowed to develop
into adults and were randomly assessed for RFP and GFP expression with confocal
microscopy. DIC and fluorescent images were overlaid with ImageJ software. (A) GFP
signal overlaid with DIC image, (B) RFP signal overlaid with DIC image, (C) GFP and
RFP signal overlaid with DIC image. Co-localized pixels are visualized as yellow.
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DISCUSSION
Historically, investigations of the function of the nascent polypeptide-associated
complex (NAC) in C. elegans have been conducted in the context of beta subunit
depletions. These studies lack the depletion of the entire complex and, instead leave the
alpha subunit in relative excess. Previous research has indicated that there are individual
functions that each subunit can perform when not complexed with its binding partner.
Alpha NAC has been implicated as a transcription factor regulating cell differentiation22–
25

. Conversely, beta NAC has not been as well characterized as alpha NAC as an

individual subunit, but was originally identified as a transcription factor, and may play a
role as a cytosolic chaperone when not bound by alpha NAC 15. From previous research,
one can conclude that these subunits likely function independently and therefore,
phenotypes associated with the depletion of one subunit may be related to the loss of the
NAC, the activity of the other subunit, or both. These studies investigated the depletion
of individual subunits and the depletion of both subunits simultaneously to determine
any differential effects as related to gut cell development and viability.
The level of Gut::RFP signal is indicative of the amount of this peroxisomal
fusion protein present in the organism. A relatively low level of this protein could result
from two outcomes: fewer peroxisomes present in the gut cells or fewer gut cells present
in the organism. The first scenario could result from no significant change in the number
of differentiated gut cells but rather, is a measure of the number of peroxisomes. The
second scenario could result from a significant change in the number of differentiated gut
cells indicated by the number of peroxisomes present within each cell. For the remainder

49	
  

	
  
of this interpretation, we are hypothesizing that changes in peroxisome RFP signal are
due to an effect on gut cell differentiation, and not on peroxisome biogenesis.
From the data presented, the percentage of Gut::RFP signal present within the
three-fold and four-fold staged embryos showed a significant difference when comparing
all RNAi treatments with the controls. Specifically, parental worms exposed to any NAC
subunit depletion produced fewer embryos with Gut::RFP signal relative to untreated
controls (Table 1 and 2). As such, depletion of alpha NAC, beta NAC or both affected the
likelihood of progeny embryos displaying RFP signal. One interpretation of these results
is a loss of gut cells in embryos unable to cope with the misfolded protein stress present,
leading to debilitation and perhaps even death. Conversely, those embryos that do express
Gut::RFP in the face of the misfolded protein stress may have generated a robust stress
response that maintains the viability of the gut cell. This response may also display
different phenotypic profiles depending specifically on the corresponding depletion. To
characterize such putative differences, we proceeded to quantify the Gut::RFP signals
generated in the RNAi treatment populations. When interpreting data, one must consider
that this is a narrowed population view in terms of those embryos that survived the RNAi
(icd-1(RNAi) icd-2(RNAi), or icd-1/icd-2(RNAi)) treatments and also expressed
detectible Gut::RFP signal.
Mean pixels per area unit quantifies the number of pixels throughout an individual
embryo. This assessment can be used as a direct measure of level of peroxisomal fusion
protein expression within the embryo and, therefore, the number of peroxisomes within
gut cells. Overall, the three-fold and four-fold stages of the RNAi (icd-1(RNAi) icd2(RNAi), or icd-1/icd-2(RNAi)) treatments showed a significant increase in mean pixels
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per area unit from the control treatment. Under the previous assumption that Gut::RFP
signal is indicative of the number of gut cells, this increase in mean pixels per area unit
could indicate a larger number of differentiated gut cells. Premature or atypical
differentiation is a documented response to cell stress in other organisms, which could
explain this increase in gut cells during NAC depletion in C. elegans. Notably, within the
12 hour time point, all RNAi treatments were significantly different from each other in
terms of average RFP signal generated. These results support the hypothesis that
phenotypes associated with depletion of one subunit may be the result of both the loss of
the NAC and the activity of the remaining, unbound subunit. This difference suggests
that when in excess of its binding partner, the alpha or beta subunit has different
functions within the cell than they do when in complex with each other. When comparing
the average RFP signal generated in each population, trends emerge: icd-1(RNAi) had the
largest average RFP signal per embryos followed by icd-2(RNAi) and the icd-1/icd2(RNAi). The icd-1(RNAi) has excess alpha NAC present relative to beta NAC and also
has the highest value of mean pixels per area unit that could indicate more differentiated
gut cells. These results are consistent with alpha NAC’s known roles in other systems as
a transcription factor associated with cell differentiation22,24,25. In those cases, alpha NAC
facilitates the differentiation of cells that generate high levels of protein at some point
during their progression, e.g. the making of bone matrix as an osteoblast converts to an
osteocyte22,23. These results are also consistent with stress-induced differentiation of
mammalian intestinal and esophageal cells undergoing misfolded protein stress26.
Mean pixel intensity quantifies the number of Gut::RFP fusion proteins
occupying a defined space within the cell. This measurement could be indicative of two
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different phenomena: the inappropriate differentiation of other cell types under stress to
become gut cells, or the premature differentiation of stressed gut cells relative to other
gut cells within the same organism. In the former situation weak Gut::RFP pixel intensity
may be due to inappropriate differentiation of cells not destined to become gut cells. This
situation could be interpreted in relation to the functionality of the peroxisomes; these
cells were never intended to be gut cells, and therefore may have a decreased capacity to
make peroxisomes relative to normal gut cells, resulting in decreased mean pixel
intensity. The second interpretation of differential Gut::RFP pixel intensity would
potentially indicate the premature differentiation of a gut cell. If misfolded protein stress
has driven a gut cell to differentiate prematurely, the accumulation of peroxisomes
would be greater in those cells relative to neighboring gut cells that may have
differentiated in the appropriate time frame. Therefore, a higher mean pixel intensity
could be the result of misfolded protein stress driving a gut cell to differentiate
prematurely.
Future studies to distinguish between inappropriate differentiation and the specific
timing of differentiation could observe individual cells destined to develop into gut cells.
These cell lineage observations would follow each individual cell throughout their
development during depletion of the individual subunits of the NAC to monitor the
specific time and place of differentiation as determined by the appearance of the reporter
signal. Individual gut cell boundaries could be marked to quantify the number of
individual peroxisomes within the cell. This assessment would distinguish between an
increase in number of peroxisomes in gut cells versus an increase in gut cells and
therefore the number of peroxisomes. The three-fold and four-fold stages of the RNAi
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(icd-1(RNAi) icd-2(RNAi), and icd-1/icd-2(RNAi)) treatments showed a significant
decrease in mean pixel intensity from the control treatment. This suggests that there were
gut cells that differentiated inappropriately due to the cell stress response and these gut
cells have lower functionality within their peroxisomes than the gut cells that were
destined to differentiate under normal cellular conditions. The lower functionality of the
peroxisomes is indicated by the significant decrease in the reporter fusion protein that is
produced within peroxisomes. Overall, icd-1(RNAi) had a larger mean pixel intensity
value than icd-2(RNAi) and was statistically significant at the 24 hour time point of the
four-fold stage embryos. As previously stated, RNAi assays have a spectrum of effects
within the treatment, the range of data values for the majority of the reported time points
for both stages of embryos does not indicate any significance. With the continuation of
trials, more distinct and statistically significant trends may emerge to support the
preliminary evidence that we have defined at the 24 hour time point for four-fold stage
embryos.
From the conducted Student’s T-test between the three-fold stage and four-fold
stage embryos values for mean pixels per area unit and the mean pixel intensity, overall,
no significant difference was found. The only statistically significant difference between
the three-fold and four-fold stage embryos was during icd-1(RNAi) treatment at the 24
hour time point and as such, no discernable trend in differences can be made between the
two stages of embryos. In general, all RNAi treatments in both stages of embryos
rendered the same trends: more gut cells differentiated inappropriately as indicated by the
higher amount of mean pixels per area unit compared to the control treatment. However,
this increase in differentiated gut cells resulting from all RNAi treatments did not
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generate cells with the same functionality or the same time of differentiation as the
control treatment as indicated by mean pixel intensity. These results may indicate that
misfolded protein stress may be driving cells into early or atypical gut cell differentiation,
but these cells are not adhering to a fully completed differentiation program, resulting in
partially functional gut cells.
Along with differentiation as a response to cell stress, the upregulation of
chaperones can also occur, depending on cell type. Heat shock protein 4 (HSP-4) has
been previously studied as a chaperone that is upregulated specifically during times of
misfolded protein stress in the ER of C. elegans12. From these findings, there is evidence
that the individual NAC subunits have functions related to the regulation of
differentiation. We are now interested to determine how specific cell types respond to
misfolded protein stress through upregulation of HSP-4. Increased expression of HSP-4
indicates the engagement of UPR mechanisms focused on saving the cell and avoiding
the initiation of apoptosis.
The hsp-4::GFP/Gut::RFP reporter strain combines the ability to use HSP-4::GFP
signal as a reporter for the management of cell stress with the ability to specifically
identify gut cells within the animal. Using this co-expressing strain, we can now
specifically monitor the expression of HSP-4, a cell saving UPR outcome, in gut cells in
real time. These data establishes baseline co-localization data of HSP-4::GFP and
Gut::RFP for comparison with localization data gathered from icd-1(RNAi), icd2(RNAi), or icd-1/icd-2(RNAi) treatments. Future studies will investigate the RNAi (icd1(RNAi) icd-2(RNAi), or icd-1/icd-2(RNAi)) treatments to determine any statistically
significant deviation from this baseline control data. Additionally, future studies to

54	
  

	
  
investigate other cell lineages, specifically neuronal and muscle cell lineages, would
compare the cell-specific ability to manage stress in a similar way. Utilizing HSP-4::GFP
as an indicator of stress management, the co-localization of cell lineage signals (gut,
neuronal, and muscle) and the HSP-4::GFP would allow for the determination of cell
specific stress responses. The working hypothesis is that neurons are unable to upregulate
HSP-4 efficiently to cope with stress conditions resulting in a greater susceptibility to
apoptosis. An accompanying hypothesis is that there are cell types such as gut and
muscle cells, are able to upregulate HSP-4 effectively and resist apoptosis in the face of
misfolded protein stress. This research has implications for neurodegenerative diseases in
the context that neuronal cells are more susceptible to cell stress and will induce cellkilling mechanisms.
In conclusion, the protocol we’ve developed throughout this research has
optimized the parameters used to determine the effects of NAC depletion on cell
differentiation , specifically in the gut cells of C. elegans. With this methodology,
differentiation of muscle and neuronal cells in NAC-depleted C. elegans can be observed
and quantified using confocal microscopy to determine cell-type specific differentiation
patterns under stress conditions. Furthermore, our work provides a framework for
determining the upregulation of HSP-4 as a cell specific stress responses for gut, muscle,
and neuronal cells in NAC-depleted C. elegans. These future studies will elucidate any
differences in cell-type specific responses to misfolded protein stress, providing insights
into why certain cell types are more susceptible to death during misfolded protein stress,
and how this sensitivity could contribute to the development of disease.
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